YIH
MRNS

Y-Intercept (HK)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Y-Intercept (HK)’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-106,942
Closed -$125K – 1931
2024
Q2 		$125K Buy
106,942
+81,182
+315% +$203K 0.01% 1236
2024
Q1 		$233K Buy
+25,760
New +$250K 0.02% 1082
2023
Q2 		– Sell
-14,479
Closed -$99.9K – 1827
2023
Q1 		$99.9K Buy
+14,479
New +$90.8K 0.01% 1055

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Y-Intercept (HK)'s MRNS Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2024, closing a stake of 106,942 shares — an estimated $125K sold.

Y-Intercept (HK) first reported a position in MRNS in Q1 2023 and held it in 3 quarters. The position peaked at $233K in Q1 2024. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 106,942 Marinus Pharmaceuticals, Inc shares in Q3 2024, an estimated $125K.
  • Y-Intercept (HK) first reported a position in Marinus Pharmaceuticals, Inc in Q1 2023 and held it in 3 quarters.
  • Y-Intercept (HK)'s Marinus Pharmaceuticals, Inc position peaked at $233K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.